112 related articles for article (PubMed ID: 15563404)
1. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
Venturelli D; Mariano MT; Szczylik C; Valtieri M; Lange B; Crist W; Link M; Calabretta B
Cancer Res; 1990 Nov; 50(22):7371-5. PubMed ID: 2224864
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
4. [Effect of WT1 antisense oligonucleotide on proliferation and apoptosis of human leukemia cells].
Wu X; Wang Y; Pei X
Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):631-3. PubMed ID: 11721364
[TBL] [Abstract][Full Text] [Related]
5. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
6. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
7. Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression.
Waki M; Kitanaka A; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
Biochem Biophys Res Commun; 1994 Jun; 201(2):1001-7. PubMed ID: 7516155
[TBL] [Abstract][Full Text] [Related]
8. Different effects of an oligonucleotide uptake stimulating protein on leukemic cells in their primitive and differentiated state.
Tóth G; Schlammadinger J; Sipka S; Kiss A; Szegedi G; Rák K; Szabó G
FEBS Lett; 1998 Jul; 430(3):241-5. PubMed ID: 9688547
[TBL] [Abstract][Full Text] [Related]
9. Multigene targeting with antisense oligodeoxynucleotides: an exploratory study using primary human leukemia cells.
Opalinska JB; Machalinski B; Ratajczak J; Ratajczak MZ; Gewirtz AM
Clin Cancer Res; 2005 Jul; 11(13):4948-54. PubMed ID: 16000594
[TBL] [Abstract][Full Text] [Related]
10. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.
Simons M; Edelman ER; DeKeyser JL; Langer R; Rosenberg RD
Nature; 1992 Sep; 359(6390):67-70. PubMed ID: 1522889
[TBL] [Abstract][Full Text] [Related]
11. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Anfossi G; Gewirtz AM; Calabretta B
Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of v-myb oncogene or c-myb proto-oncogene in insect cells: characterization of newly induced nucleolus-like structures accumulating Myb protein.
Stokrová J; Korb J; Pliss A; Raska I; Stulík J; Dvoráková M
Int J Mol Med; 2002 May; 9(5):547-54. PubMed ID: 11956664
[TBL] [Abstract][Full Text] [Related]
13. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
[TBL] [Abstract][Full Text] [Related]
14. Technology evaluation: leukemia therapy, University of Pennsylvania.
Orr RM
Curr Opin Mol Ther; 1999 Jun; 1(3):399-403. PubMed ID: 11713805
[TBL] [Abstract][Full Text] [Related]
15. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
[TBL] [Abstract][Full Text] [Related]
16. Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb.
Moon IJ; Lee Y; Kwak CS; Lee JH; Choi K; Schreiber AD; Park JG
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):295-303. PubMed ID: 10677346
[TBL] [Abstract][Full Text] [Related]
17. Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562.
Kasono K; Heike Y; Xiang J; Piché A; Kim HG; Kim M; Hagiwara M; Nawrath M; Moelling K; Curiel DT
Cancer Gene Ther; 2000 Jan; 7(1):151-9. PubMed ID: 10678368
[TBL] [Abstract][Full Text] [Related]
18. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
19. c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells.
Afroze T; Sadi AM; Momen MA; Gu S; Heximer S; Husain M
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1305-11. PubMed ID: 17363689
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON].
Ou X; Tan T; Li Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1096-100. PubMed ID: 17121362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
